Chemotherapy-induced Cardiotoxicity and Mitigation

SEP 10, 2026 · JOURNAL ARTICLE

Management of Severe Valvular Heart Disease in Patients with Active Cancer: A French Multidisciplinary Position Paper

European Heart Journal - Valvular and Structural Heart Disease

A multidisciplinary consensus position paper providing evidence-based suggestions for managing severe valvular heart disease in active cancer patients, without reporting original trial data.

SEP 10, 2026 · JOURNAL ARTICLE

Current clinical applications and future developments of platinum-based anticancer drugs

Jbic Journal of Biological Inorganic Chemistry

A descriptive comparative analysis of guideline recommendations, utilization patterns, and research directions without primary efficacy or safety outcome data; provides context on current practice but no new clinical evidence.

SEP 10, 2026 · JOURNAL ARTICLE

Longitudinal Changes in QTc Interval in Cancer Patients After the Initiation of Systemic Therapy: Analysis of the ONCOECHO Study Cohort

Cancers

A single-centre observational cohort study with surrogate ECG endpoints and modest sample size (n=291) examining QTc changes during cancer therapy; findings on QTc prolongation risk are descriptive and hypothesis-generating rather than practice-changing.

SEP 9, 2026 · JOURNAL ARTICLE

Venous Thromboembolism in Patients Receiving Vascular Endothelial Growth Factor-Targeted Therapy

Journal of Vascular Diseases

A comprehensive narrative review synthesizing evidence from trials, observational studies, and pharmacovigilance to provide clinical guidance on VTE risk, mechanisms, and management in VEGF-inhibitor-treated patients.

SEP 9, 2026 · JOURNAL ARTICLE

Combined C-reactive protein, procalcitonin, and microalbuminuria panel for contrast-induced nephropathy risk stratification after percutaneous coronary intervention

Frontiers in Cardiovascular Medicine

A retrospective single-centre study of 486 patients demonstrating that a three-biomarker panel outperforms existing risk scores for a surrogate endpoint (serum creatinine change), with clear effect sizes but requiring prospective validation and generalization to cardio-oncology populations.

SEP 9, 2026 · JOURNAL ARTICLE

Rationale and design of the: breast cancer, fitness and exercise for heart health (BE-FITTER trial)

Cardio-oncology

This is a rationale-and-design paper for a small, single-centre RCT that has not yet reported results; it describes planned methods and hypotheses rather than outcomes.

SEP 8, 2026 · JOURNAL ARTICLE

Development and Validation of a Thoracic Aortic Calcification-Based Nomogram for Early Myocardial Injury in Breast Cancer Patients

Journal of Cardiovascular Development and Disease

A retrospective nomogram development and validation study in a single centre with good discrimination metrics (AUROC 0.901) and internal validation, but based on a surrogate endpoint (elevated troponin) rather than hard clinical outcomes, limiting generalizability.

SEP 7, 2026 · JOURNAL ARTICLE

Quality standards for preclinical research in cardio-oncology

European Heart Journal

A Scientific Statement outlining quality standards and best practices for preclinical cardio-oncology research, intended to promote standardization, reproducibility, and rigor in the field.